About
Vensica Medical is an Israeli company founded in 2015 that specializes in urology therapeutics. The company focuses on innovative drug delivery technologies for urinary bladder conditions. Its proprietary platform, Vibe®, utilizes ultrasound-assisted, needle-free technology to deliver medications directly into the bladder wall. This method allows for controlled and localized treatment, minimizing the discomfort and risks associated with traditional needle injections. The lead product, ViXe, combines the FDA-approved botulinum neurotoxin A (Xeomin®) with the Vibe device to offer a minimally invasive treatment for conditions like overactive bladder, neurogenic bladder, and interstitial cystitis. Vensica's technology aims to enhance patient comfort and treatment effectiveness while reducing complications. The company has received significant funding to support its ongoing clinical trials in the US and Europe, focusing on improving therapeutic options for patients with urological disorders. Vensica collaborates with pharmaceutical and medical device partners to expand its technology and therapeutic applications.
Technologies
Keywords
Company Information
- Employees11
- Founded2014
- Annual Revenue$3000000
- Total Funding$32500000
Location
Netanya, Center District, Israel
